(19)
(11) EP 3 302 358 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.09.2019 Bulletin 2019/38

(45) Mention of the grant of the patent:
07.08.2019 Bulletin 2019/32

(21) Application number: 16734047.0

(22) Date of filing: 08.06.2016
(51) International Patent Classification (IPC): 
A61F 2/14(2006.01)
 A61F 9/007(2006.01)
(86) International application number:
PCT/IL2016/050597
(87) International publication number:
WO 2016/199139 (15.12.2016 Gazette 2016/50)

(54)

KERATOPROSTHESIS

KERATOPROSTHESE

KÉRATOPROTHÈSE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 08.06.2015 US 201562172588 P

(43) Date of publication of application:
11.04.2018 Bulletin 2018/15

(73) Proprietor: Corneat Vision Ltd
4366411 Raanana (IL)

(72) Inventor:
  • LITVIN, Gilad
    4493500 Moshav Sde Varburg (IL)

(74) Representative: Pearl Cohen Zedek Latzer Baratz UK LLP 
The Gridiron Building One Pancras Square
London N1C 4AG
London N1C 4AG (GB)


(56) References cited: : 
EP-A1- 0 446 197
WO-A1-02/089709
US-A- 5 282 851
 WO-A1-02/43622
WO-A1-2009/135068
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).